TSE:4577Pharmaceuticals
Daito Pharmaceutical (TSE:4577) Profit Margin Drop Challenges Growth Story
Daito Pharmaceutical (TSE:4577) reported a forecasted earnings growth of 17.2% per year and projected revenue growth of 4.5% per year, just outpacing the broader Japanese market’s 4.4% expectation. However, its net profit margin slipped to 3.9% from last year’s 6.8%, marking a noticeable decrease in profitability. Shares are trading at ¥1,184, below the estimated fair value, but its P/E ratio of 17.9x is higher than the peer and industry averages. While high quality earnings and promising...